Casco Systems Donates Engineering Services to Create The X-VENT Ventilator PostedThursday, July 9,2020 at 4:58 PM Casco Systems Donates Engineering Services to Create The X-VENT Ventilator Casco Systems, a Maine based electrical engineering firm specializing in automation, integration and electrical systems, is announcing its collaboration with Enexor Health Systems, formerly Breathe Strong, LLC, to develop the X-VENT – an emergency, positive pressure ventilator designed to treat patients with respiratory insufficiency or failure. Amidst the initial phases of the COVID-19 pandemic, Enexor BioEnergy Director of Engineering Scott Auerbach contacted Casco Systems about supporting the electrical, instrumentation, and automation controls design of a fast-tracked project. A long-time client and supporter of Casco Systems, Auerbach knew Casco had the breadth of knowledge and reputation for solving complex challenges on tight budgets and timelines. Casco Systems embraced the opportunity to support this effort. Ultimately, Kevin Mahoney, President & Founder, decided to donate Casco Systems’ services at no cost to this worthwhile endeavor. Casco Systems began work immediately to develop the electrical controls hardware design, system functional specification and a complete programmed automation package. “I wasn’t alone in realizing that this project was important on every level. The whole Casco team felt a sense of pride in what was being asked of us. In a time where many felt helpless, we were approached with an incredible opportunity not only to make a positive contribution during the pandemic but to create something that could save lives. Providing our services pro bono benefited this project as well as the hospitals and patients who would depend on X-VENT’s lifesaving technology. I hope the savings will contribute to the affordability of the ventilators and the number of units that Enexor is able to donate,” said Mahoney. Todd Ward, Vice President of Engineering at Casco Systems, managed the project engineering taskforce. Engineers Chris Parent and Chris Hurd worked around the clock to create a fully functional beta system that was in testing and fully operational in less than 3 weeks. Further development and refinements came over the next 3 weeks with final submittal to the FDA, occurring 6 weeks after inception. “In order to fast track X-VENT’s complex product development lifecycle, that under normal circumstances takes years, the Casco team needed to draw from our experience and diverse background to implement best practices from other industries. The success of this project depended on a nationwide collaboration of experts in medicine, engineering, design, and producers of essential components. Casco was able to leverage our industry network to quickly enlist the help of numerous suppliers who provided assistance in identifying key components that could not only meet the technical requirements but could also ramp up production to supply the required volume in order to meet the short and long term production goals,” said Hurd. In its entirety, the X-VENT ventilator provides mechanical ventilatory support to patients suffering from respiratory insufficiency or respiratory failure. The ventilator utilizes state-of the-art industrial control algorithms and equipment to control a piston with variable stroke length, acceleration, and speed to mimic the functionality of the human lungs. Medical professionals set critical parameters from a touchscreen display that communicates with the machine’s control system that is responsible for sending commands to the piston. Unlike many emergency ventilators currently in development, the X-VENT uses a precision ground piston to supply breathing air to patients. This system operates with fewer limitations and complications than the Bag Valve Mask technology being implemented by other similar products. Enexor BioEnergy publicly announced that the X-VENT would be manufactured domestically at Enexor’s facilities in Tennessee and Alabama. Production may also expand abroad to meet international demand. The X-VENT was designed and will be distributed to address medical equipment shortages. As soon as necessary approval is granted, Enexor plans to donate and sell the X-VENT to Ghana, the Dominican Republic, Panama, and in countries where hospitals are remote and isolated. X-VENT received FDA Emergency Use Authorization this month and will seek full FDA approval by the end of the year. Learn more at https://www.casco-systems.com/xvent.